Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
The results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that
Read MoreThe results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that
Read MoreThe Viking study results add to the growing excitement around the biotech company and its potential in the budding weight
Read MoreAmgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after
Read MoreA major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. Source
Read MoreSome patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly
Read MoreMedicare patients can soon get coverage for Novo Nordisk's Wegovy as long as it is prescribed to reduce their risk
Read MoreDrugmakers are racing to catch up to Madrigal Pharmaceuticals, which has the first drug for NASH liver disease. Meanwhile, AI
Read MoreSome health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say
Read MoreThe FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are
Read More